Clinical trial
Thiamine as a Metabolic Resuscitator in Septic Shock
NCT01070810 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thiamine as a Metabolic Resuscitator in Septic Shock
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- November 30, 2014
- Enrollment
- 88 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock